Finance

Lists
002688:SHE
Jinhe Biotechnology Co Ltd
CN¥4.99
+0.60%
(+0.030) 1D
Oct 16, 2:32:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002688...
Open
CN¥4.99
High
CN¥5.08
Low
CN¥4.97
Mkt. cap
4.33B
Avg. vol.
10.85M
Volume
5.94M
Dividend
2.00%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 1, 2026
P/E ratio
148.12
52-wk high
CN¥7.00
52-wk low
CN¥4.58
EPS
CN¥0.03
Shares outstanding
837.38M
No. of employees
3K
Open
CN¥4.99
High
CN¥5.08
Low
CN¥4.97
Mkt. cap
4.33B
Avg. vol.
10.85M
Volume
5.94M
Dividend
2.00%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 1, 2026
P/E ratio
148.12
52-wk high
CN¥7.00
52-wk low
CN¥4.58
EPS
CN¥0.03
Shares outstanding
837.38M
No. of employees
3K
News stories
From web sources and news partners
About Jinhe Biotechnology Co Ltd
CEO-
Employees2.71K
FoundedMar 14, 1990
Headquarters-
SectorPharmaceutical industry
Websitejinhe.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
645.94M
841.90M
741.88M
705.79M
Cost of goods sold
437.99M
596.11M
477.57M
431.75M
Cost of revenue
437.99M
596.11M
477.57M
431.75M
Research and development expenses
39.13M
30.94M
19.44M
22.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.79M
126.30M
136.75M
126.29M
Operating expense
171.63M
177.94M
160.24M
155.96M
Total operating expenses
609.61M
774.05M
637.80M
587.71M
Operating income
36.33M
67.85M
104.08M
118.08M
Other non operating income
-4.20M
2.00M
-6.68M
4.30M
EBT including unusual items
1.12M
-121.60M
76.97M
99.53M
EBT excluding unusual items
12.81M
42.27M
78.17M
92.22M
Income tax expense
4.29M
24.16M
13.63M
27.69M
Effective tax rate
382.50%
-19.87%
17.71%
27.83%
Other operating expenses
-13.29M
18.61M
2.17M
6.98M
Net income
1.15M
-111.51M
62.30M
68.60M
Net profit margin
0.18%
-13.25%
8.40%
9.72%
Earnings per share
-
-
-
-
Interest and investment income
1.28M
5.19M
1.06M
5.45M
Interest expense
-20.94M
-24.00M
-20.29M
-21.15M
Net interest expenses
-19.66M
-18.80M
-19.22M
-15.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
82.63M
125.26M
161.49M
180.89M
Gain or loss from assets sale
75.91K
2.73M
-
563.11K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps